U.S.
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
▲ Sign in to vote stories up
Coverage 1 source · 1 report
Chronological.
-
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Thinking of quitting a GLP-1? A physician outlines six risks, from weight regain and muscle loss to worsening biomarkers and mental health consequences.
Discussion 0 comments